Schrodinger, Inc. (SDGR)
About Schrodinger, Inc.
Schrodinger Inc is a healthcare-based software company. It offers software solutions designed to support and accelerate the discovery, design, and optimization of molecules. The company operates in two reportable segments: Software and Drug Discovery. The software segment is focused on selling software to transform drug discovery across the life sciences industry, as well as to customers in materials science industries. The drug discovery segment is focused on generating revenue from a diverse portfolio of preclinical and clinical programs, internally and through collaborations, that have various stages of discovery and development. The majority of the company's revenue is derived from the Software segment. Geographically, it derives the maximum revenue from the United States.
This profile is unclaimed. An authorized representative can claim it free to control the page and activate the embeddable Verified badge.
Financial summary
- Revenue FY2025
- $255.9M
- Net income
- -$103.3M
- Total assets
- $726.2M
- Market cap
- $1.1B
Source: SEC EDGAR · updated Jun 7, 2026
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $1.1B
- Shares outstanding
- 47.0M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Feb 6, 2020
Schrodinger, Inc. (SDGR) Stock Price
- Reported a net loss of $103.3M in FY2025.
- Trading 27% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Schrodinger, Inc..
Write a review
News about Schrodinger, Inc.
News & sentiment via Polygon.io
Schrodinger, Inc.: frequently asked questions
Is Schrodinger, Inc. an American company?
Schrodinger, Inc. is a US-based company headquartered in New York, New York, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Schrodinger, Inc. headquartered?
Schrodinger, Inc. is headquartered in New York, New York, United States.
Is Schrodinger, Inc. publicly traded?
Yes — Schrodinger, Inc. is a publicly traded company. Its stock trades under the ticker symbol SDGR on the NASDAQ.
What does Schrodinger, Inc. do?
Schrodinger, Inc. is an American Pharmaceuticals company in the Health & Beauty sector.
